PSP001 - A First-in-disease human PEGIFN-λ Chimera
Feb 3rd 2021. FDA issued letter "Safe-to-proceed"; |
Date:2019-08-05 18:47:43 | Visits: |
Prev:Dr. Hongyu Liu, CEO of Prosit Sole Biotechnology (Beijing) attended the Hong Kong Summit of Winner of Nobel Prize and Turing Award at International Center of Innovative Technology, as a leader of inno Next:May 3rd,2021 Phase 1 Site Initiation Visit; |